APPLICATION
ANDA200250
TYPE
ANDA
ORIGINAL APPROVAL
2011-06-20
LATEST ACTION
2024-09-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LEVOFLOXACINPrescription
LEVOFLOXACIN 500MG · TABLET · ORAL
LEVOFLOXACINPrescription
LEVOFLOXACIN 750MG · TABLET · ORAL
LEVOFLOXACINPrescription
LEVOFLOXACIN 250MG · TABLET · ORAL
Approval history
2024-09-20Labeling · Supplement 7 · standardAP
2020-11-10Labeling · Supplement 6 · standardAP
2020-11-10Labeling · Supplement 5 · standardAP
2019-05-03Labeling · Supplement 4 · standardAP
2012-03-29Labeling · Supplement 2AP
2011-08-02Labeling · Supplement 1AP
2011-06-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.